Back
BeyondSpring 10K Form
Buy
55
BYSI
BeyondSpring
Last Price:
$1.67
Seasonality Move:
17.16%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BYSI News And Ratings
See the #1 stock for the next 7 days that we like better than BYSI
BYSI Financial Statistics
Sales & Book Value
| Annual Sales: | $1.8M |
|---|---|
| Cash Flow: | $-4.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.70 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -0.32000 |
|---|---|
| Net Income (TTM): | $-12.3M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | -59.43% |
BeyondSpring Earnings Forecast
Key BeyondSpring Financial Ratios
-
Per Share Earnings over the last 11 years have been positive in 6 years.
BeyondSpring Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | BYSI |
| CUSIP: | G10830 |
| Website: | beyondspringpharma.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.82 |
| Quick Ratio: | 1.75 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
BYSI Technical Analysis vs Fundamental Analysis
Buy
55
BeyondSpring (BYSI)
is a Buy
Is BeyondSpring a Buy or a Sell?
-
BeyondSpring stock is rated a BuyThe current BeyondSpring [BYSI] share price is $1.68. The Score for BYSI is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.